Dec 1, 2011
By:
Jill Wechsler
Agency expansion and globalization promote innovation, collaboration, and organizational changes
|
Nov 1, 2011
By:
Jill Wechsler
Clamor for critical therapies prompts probes of prices, production practices.
|
Oct 1, 2011
By:
Jill Wechsler
Sidney Wolfe, MD, Director, Public Citizen's Health Research Group
|
Oct 1, 2011
By:
Jill Wechsler
Francis Collins, MD, PhD, Director, National Institutes of Health
|
Oct 1, 2011
By:
Jill Wechsler
Henry Waxman, Congressional Representative from Los Angeles, California
|
Oct 1, 2011
By:
Jill Wechsler
Janet Woodcock, MD, Director, FDA Center for Drug Evaluation and Research
|
Oct 1, 2011
By:
Jill Wechsler
Marck McClellan, MD, Director, Engelberg Center for Health Reform, Brookings Institute
|
Sep 1, 2011
By:
Jill Wechsler
User-fee renewal legislation sets the stage for new policies affecting reimbursement, research, and regulatory oversight.
|
Aug 1, 2011
By:
Jill Wechsler
A number of important decisions from the Supreme Court will affect drug marketing, research, and regulation
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
